Table 1.
Baseline characteristics of the study population
| Total sample | Subjects without LVH | Subjects with LVH | |
|---|---|---|---|
|
N |
968 |
820 |
148 |
|
Sex (% women) |
30.5 |
30.6 |
29.7 |
|
Age (years) |
67.1 (±5.7) |
66.7 (±5.7) |
69.4 (±5.2) |
|
Systolic BP (mmHg) |
146.0 (±19.3) |
145.1 (±19.0) |
150.8 (±20.2) |
|
Diastolic BP (mmHg) |
84.5 (±10.2) |
84.2 (±10.0) |
86.6 (±11.3) |
|
Antihypertensive and/or cardioprotective treatment (%) |
41.3 |
37.8 |
60.8 |
|
Hypertension (%) |
74.5 |
71.5 |
91.1 |
|
BMI |
27.3 (±3.8) |
26.9 (±3.4) |
29.8 (±4.8) |
| FPG (mmol/l)* | 5.8 [0.9] | 5.8 [1.0] | 6.1 [1.0] |
Data are expressed as mean (±SD) or median [interquartile range (IQR)]*. BP blood pressure, BMI body mass index, FPG fasting plasma glucose.